Literature DB >> 4082779

Cytochalasin D accelerates the release of Newcastle disease virus from infected cells.

T G Morrison, L J McGinnes.   

Abstract

The role of the cellular cytoskeleton in Newcastle disease virus (NDV) infection was explored in two ways. First, the extent of the association of viral proteins with the cytoskeletal fraction of chicken embryo cells was determined. NDV-infected cells, pulse-labelled with [35S]methionine with or without a subsequent chase, were fractionated into Triton X-100-soluble and cytoskeletal fractions. All NDV proteins become associated with the cytoskeletal fraction of cells subsequent to their synthesis. Mixing experiments provided evidence against nonspecific sticking of proteins with this cell fraction. Second, the functional significance of the cytoskeletal association was explored using the inhibitor cytochalasin D. In the presence of this inhibitor, the rate of release of radioactively labelled virions was accelerated 2.5-fold. Colchicine did not significantly alter the rate of virion release. Virus particles released from cytochalasin D-treated cells had the same density as virions released from untreated cells, but were slightly less infectious and contained less actin. These results suggest that functional microfilaments do not play an obligatory role in viral morphogenesis but rather function to slow virus particle release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4082779     DOI: 10.1016/0168-1702(85)90023-1

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  12 in total

1.  Transmembrane domain of influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK cells.

Authors:  A Kundu; R T Avalos; C M Sanderson; D P Nayak
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

2.  Host cell dependence of viral morphology.

Authors:  P C Roberts; R W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

3.  Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles.

Authors:  Jason P Laliberte; Lori W McGinnes; Mark E Peeples; Trudy G Morrison
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

4.  Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.

Authors:  Lisa A Lopez; Su Jung Yang; Colin M Exline; Srinivas Rengarajan; Kevin G Haworth; Paula M Cannon
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

5.  Vismione B Interferes with Trypanosoma cruzi Infection of Vero Cells and Human Stem Cell-Derived Cardiomyocytes.

Authors:  Gabriele Sass; Armelle T Tsamo; Gwladys A M Chounda; Pamela K Nangmo; Nazish Sayed; Adriana Bozzi; Joseph C Wu; Augustin E Nkengfack; David A Stevens
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

6.  Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein.

Authors:  A Ali; R T Avalos; E Ponimaskin; D P Nayak
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells.

Authors:  R T Avalos; Z Yu; D P Nayak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association.

Authors:  S Barman; D P Nayak
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  F-actin modulates measles virus cell-cell fusion and assembly by altering the interaction between the matrix protein and the cytoplasmic tail of hemagglutinin.

Authors:  Hiroshi Wakimoto; Masakatsu Shimodo; Yuto Satoh; Yoshinori Kitagawa; Kaoru Takeuchi; Bin Gotoh; Masae Itoh
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Packaging of actin into Ebola virus VLPs.

Authors:  Ziying Han; Ronald N Harty
Journal:  Virol J       Date:  2005-12-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.